Replies to post #2518 on Canopus Biopharma Inc (CBIA)

[Kjv]

I mean….with this price point…the risk reward isn’t bad at all.

Just not the best of guys we are dealing with.

I didn’t like what I saw when I compared the filings.

The similarities are damning. Some names keep coming up getting unrestricted shares in both companies